[ORGANIZATION]
Icotyde
Featured in 1 tracked story · first seen
Situations
Icotrokinra clinical trial results for psoriasis
2 clusters · 5 sources · last updated
Latest: Johnson & Johnson reports long-term efficacy for oral psoriasis drug Icotyde
Johnson & Johnson has released long-term Phase 3 clinical trial data for icotrokinra (Icotyde), an oral peptide designed to treat moderate-to-severe plaque psoriasis by blocking the interleukin (IL)-23 receptor. Data fr